Respiratory Flashcards
Albuterol: classes
beta-2 adrenergic agonist
Albuterol: indications
asthma, COPD
Albuterol: PK
intermediate acting (3-6 hours); quick onset
Albuterol: PD
Binds to beta-2 receptor, produces stimulation of adenylyl cyclase (via G protein), cAMP and protein kinase levels increase, intracellular [Ca] drops, and bronchodilation occurs; also enhances mucociliary clearance, decreases microvascular permeability, and suppresses mediator release from inflammatory cells
Albuterol: tox
tachycardia, exacerbation of angina, arrhythmias, pulmonary artery vasodilation (increased V/Q mismatch), tremor, headache, hypokalemia, hyperglycemia
Albuterol: excretion
metabolized by hepatic COMT/MAO
Albuterol: special
loses selectivity with increased dose (will start to bind to beta-1 receptors); Tolerance/Tachyphylaxis –> decreased response to drug after repeated doses over a short period of time (due to decreased receptor expression)
Salmeterol: class
long-acting beta-2 adrenergic agonist
Salmeterol: indications
asthma, COPD (for prevention of bronchospasm)
Salmeterol: PD
Binds to beta-2 receptor, produces stimulation of adenylyl cyclase (via G protein), cAMP and protein kinase levels increase, intracellular [Ca] drops, and bronchodilation occurs; also enhances mucociliary clearance, decreases microvascular permeability, and suppresses mediator release from inflammatory cells
Salmeterol: PK
long acting (>12 hours), slower onset (hours)
Salmeterol: tox
tachycardia, exacerbation of angina, arrhythmias, pulmonary artery vasodilation (increased V/Q mismatch), tremor, headache, hypokalemia, hyperglycemia
Salmeterol: excretion
metabolized by hepatic COMT/MAO
Salmeterol: special
only prescribed with inhaled steroid (studies show increased risk of sudden cardiac death when taken alone); loses selectivity with increased dose (will start to bind to beta-1 receptors); Tolerance/Tachyphylaxis –> decreased response to drug after repeated doses over a short period of time (due to decreased receptor expression)
Formeterol: class
beta-2, long acting same class as Salmeterol
Formeterol: indication
asthma, COPD
Ipratropium: class
muscarinic receptor blocker (anticholinergic)
Ipratropium: indications
asthma, COPD (a bronchodilator)
Ipratropium: PD
binds to muscarinic receptor (M3), which is on smooth muscle, and blocks parasympathetic signals, leading to bronchodilation
Ipratropium: PK
slower onset than beta-2 agonists (albuterol, etc); 1% reaches systemic circulation; duration 6-8 hrs;
Ipratropium: tox
rare and only at high doses; horrible taste; Paradoxical bronchoconstriction; other rarities including tachycardia, GI dysfunction, bladder dysfunction (due to decreased parasympathetic signals)
Ipratropium: excretion
Inactive metabolites excreted in urine
Tiotropium: class
Muscurinic blocker, long acting same class as Atropine and Ipatropium
Tiotropium: indication
asthma, COPD